Cite
HARVARD Citation
Ishrat, T. et al. (2019). Dose–response, therapeutic time-window and tPA-combinatorial efficacy of compound 21: A randomized, blinded preclinical trial in a rat model of thromboembolic stroke. Journal of cerebral blood flow & metabolism. 39 (8), pp. 1635-1647. [Online].